CLINICAL TRIALS PROFILE FOR IMMUNE GLOBULIN INFUSION (HUMAN)
✉ Email this page to a colleague
All Clinical Trials for immune globulin infusion (human)
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00003335 ↗ | Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer | Completed | National Cancer Institute (NCI) | Phase 2 | 1998-01-01 | RATIONALE: Umbilical cord blood transplantation may allow doctors to give higher doses of chemotherapy or radiation therapy and kill more cancer cells. PURPOSE: This phase II trial is studying allogeneic umbilical cord blood transplantation to see how well it works when given with chemotherapy or radiation therapy in treating patients with high-risk hematologic cancer. |
| NCT00003335 ↗ | Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer | Completed | Case Comprehensive Cancer Center | Phase 2 | 1998-01-01 | RATIONALE: Umbilical cord blood transplantation may allow doctors to give higher doses of chemotherapy or radiation therapy and kill more cancer cells. PURPOSE: This phase II trial is studying allogeneic umbilical cord blood transplantation to see how well it works when given with chemotherapy or radiation therapy in treating patients with high-risk hematologic cancer. |
| NCT00003661 ↗ | Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer | Completed | Roswell Park Cancer Institute | Phase 2 | 1998-06-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage cancer cells. Umbilical cord blood transplantation may be able to replace cells destroyed by chemotherapy or radiation therapy. PURPOSE: Phase II trial to study the effectiveness of chemotherapy, radiation therapy, and umbilical cord blood transplantation in treating patients who have hematologic cancer. |
| NCT00003913 ↗ | Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease | Completed | National Cancer Institute (NCI) | Phase 2 | 1998-12-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Umbilical cord blood transplantation may be able to replace immune cells that were destroyed by the chemotherapy or radiation therapy that was used to kill cancer cells. PURPOSE: Phase II trial to study the effectiveness of umbilical cord blood transplantation plus combination chemotherapy in treating patients who have hematologic cancer or nonmalignant hematologic disease. |
| NCT00003913 ↗ | Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 | 1998-12-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Umbilical cord blood transplantation may be able to replace immune cells that were destroyed by the chemotherapy or radiation therapy that was used to kill cancer cells. PURPOSE: Phase II trial to study the effectiveness of umbilical cord blood transplantation plus combination chemotherapy in treating patients who have hematologic cancer or nonmalignant hematologic disease. |
| NCT00003913 ↗ | Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease | Completed | Fred Hutchinson Cancer Research Center | Phase 2 | 1998-12-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Umbilical cord blood transplantation may be able to replace immune cells that were destroyed by the chemotherapy or radiation therapy that was used to kill cancer cells. PURPOSE: Phase II trial to study the effectiveness of umbilical cord blood transplantation plus combination chemotherapy in treating patients who have hematologic cancer or nonmalignant hematologic disease. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for immune globulin infusion (human)
Condition Name
Clinical Trial Locations for immune globulin infusion (human)
Trials by Country
Clinical Trial Progress for immune globulin infusion (human)
Clinical Trial Phase
Clinical Trial Sponsors for immune globulin infusion (human)
Sponsor Name
